by ADRIAN MANZ | Jan 21, 2026 | The Doctor's Dose
Markets Rebound as Trade Tensions Ease Wall Street staged a broad relief rally today as stocks and bonds climbed after :contentReference[oaicite:0]{index=0} walked back his latest tariff threats toward Europe. The sudden shift eased fears of a fast-moving...
by ADRIAN MANZ | Jan 16, 2026 | The Doctor's Dose
Why Nvidia’s Stock Isn’t Partying Like Other Parts of the Chip Sector This Year The strange setup: strong AI signals, weaker relative performance Nvidia shares moved higher following strong semiconductor earnings and bullish AI-related guidance — yet they still lagged...
by ADRIAN MANZ | Jan 15, 2026 | The Doctor's Dose
Verizon Gets Final California Approval for Frontier Deal — Intraday Trading Implications Verizon (VZ) received final approval from California regulators to acquire Frontier Communications (FYBR), clearing the last major state hurdle for its $9.6B deal (valued around...
by ADRIAN MANZ | Jan 13, 2026 | The Doctor's Dose
Trump’s Iran Tariff Threat: What It Means for Markets and Traders President Donald Trump escalated tensions with Iran this week by announcing that any country doing business with the Islamic Republic would face a 25 percent tariff on trade with the United States,...
by ADRIAN MANZ | Jan 7, 2026 | The Doctor's Dose
Train the Body, Strengthen the Mind: How Exercise Builds Trading Discipline Trading is a performance discipline. If you want steadier execution, better emotional control, and cleaner decision-making, you can’t only train your charts — you have to train your body too....
by ADRIAN MANZ | Jan 7, 2026 | The Doctor's Dose
Why Intel’s Stock Surged as the AI Trade Broadened — and What Traders Should Watch Next Intel surprised the market by jumping to the top of the S&P 500 leaderboard as the AI narrative broadened beyond the usual “GPU-only” winners. For traders, this wasn’t just a...
by ADRIAN MANZ | Jan 6, 2026 | The Doctor's Dose
Boredom in Trading: Why Doing Nothing Is One of the Hardest (and Most Profitable) Skills One of the least discussed — yet most destructive — forces in active trading is boredom in trading psychology. Not fear. Not greed. Boredom. Sitting in front of a screen, watching...
by ADRIAN MANZ | Jan 6, 2026 | The Doctor's Dose
Nvidia’s “Tremendous” AI Demand Message: What Traders Should Watch as Vera Rubin Heads Toward Launch Nvidia didn’t need an earnings surprise to move the conversation this week. At CES, the company reinforced a simple narrative: Demand for AI and accelerated computing...
by ADRIAN MANZ | Jan 6, 2026 | The Doctor's Dose
Plan the Trade. Trade the Plan. Why Discipline Is the Real Edge (ATI Case Study) One of the biggest advantages in markets isn’t a new indicator, a faster feed, or a better opinion. It’s trading discipline and execution—the ability to follow your plan to the letter...
by ADRIAN MANZ | Jan 6, 2026 | The Doctor's Dose
How to Stop FOMO in Trading: When a “Right Trade” Becomes a Losing Trade Sometimes the trade idea is right… and the trader still loses. The culprit is often simple: entry discipline gets replaced by urgency. How to Stop FOMO in Trading Starts With One Truth: The Entry...
